SS
SRGA

Steve Schonfeld’s Surgalign Holdings, Inc. Common Stock SRGA Stock Holding History

Steve Schonfeld’s Portfolio SRGA Stock Details SRGA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-353
Closed -$23K – 2286
2020
Q4 		$23K Sell
353
-8,944
-96% -$583K ﹤0.01% 1521
2020
Q3 		$506K Buy
+9,297
New +$711K 0.01% 909

Other funds holding SRGA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KAM
Krensavage Asset Management New York $263M AUM 66.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
DI
DFPG Investments Sandy, Utah $1.28B AUM 27.55% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
TC
TownSquare Capital Provo, Utah $544M AUM 40.38% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

Steve Schonfeld's SRGA Position: Q1 2021 in Review

Steve Schonfeld sold out of Surgalign Holdings, Inc. Common Stock (SRGA) in Q1 2021, closing a stake of 353 shares — an estimated $23K sold.

Steve Schonfeld first reported a position in SRGA in Q3 2020 and held it in 2 quarters. The position peaked at $506K in Q3 2020. 105 funds tracked by Wall St. Rank hold SRGA as of Q1 2021.

  • Steve Schonfeld reported no remaining Surgalign Holdings, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
  • Steve Schonfeld sold 353 Surgalign Holdings, Inc. Common Stock shares in Q1 2021, an estimated $23K.
  • Steve Schonfeld first reported a position in Surgalign Holdings, Inc. Common Stock in Q3 2020 and held it in 2 quarters.
  • Steve Schonfeld's Surgalign Holdings, Inc. Common Stock position peaked at $506K in Q3 2020.
  • 105 funds tracked by Wall St. Rank held Surgalign Holdings, Inc. Common Stock as of Q1 2021.

Based on Schonfeld Strategic Advisors's 13F filing for Q1 2021, filed 17 May 2021.